×
ADVERTISEMENT

mitomycin intravesical solution

Zusduri Approved for Recurrent Low-Grade Intermediate-Risk Non–Muscle-Invasive Bladder Cancer

The FDA has approved mitomycin intravesical solution (Zusduri, UroGen Pharma) for adult patients with recurrent ...

JUNE 13, 2025

Load more